Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 401-409

  Turcotte, André ^a   Simard, Marie ^a   Morin, Nathalie J ^a   Beauchamp, Denis ^a   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFTAZIDIME;

ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; ELECTRON MICROSCOPY; ENTEROBACTER CLOACAE; FEMALE; FIBRIN CLOT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RABBIT; SERRATIA MARCESCENS; TISSUE DISTRIBUTION;

EID: 0031039998     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.401     Document Type: Article

References (18)

1. Bergeron, M. G., D. Beauchamp, A. Poirier, and A. Bastille. 1981. Continuous vs intermittent administration of antimicrobial agents: tissue penetration and efficacy in vivo. Rev. Infect. Dis. 3:84-97.
2. Bergeron, M. G., B. M. Nguyen, S. Trottier, and L. Gauvreau. 1977. Penetration of cefamandole, cephalothin, and desacetylcephalothin into fibrin clots. Antimicrob. Agents Chemother. 12:682-687.
3. Bergeron, M. G., J. Robert, and D. Beauchamp. 1993. Pharmacodynamics of antibiotics in fibrin clots. J. Antimicrob. Chemother. 31(Suppl. D):113-136.
4. Boccazzi, A., M. Langer, M. Mandelli, A. M. Ranzi, and R. Urso. 1989. The pharmacokinetics of aztreonam and penetration into the bronchial secretions of critically ill patients. J. Antimicrob. Chemother. 23:401-407.
5. Clergeot, A., D. Steru, M.-A. Rosset, and C. Carbon. 1989. Efficacy and safety of low dose aztreonam in the treatment of moderate to severe Gram-negative bacterial infections. J. Antimicrob. Chemother. 23:753-758.
6. De Klerk, S., L. Walters, M. Van Wyk, S. M. Harding, A. M. Paton, and J. Ayrton. 1983. Pharmacokinetics of ceftazidime in male and female volunteers. Antimicrob. Agents Chemother. 23:892-896.
7. Drusano, G. L., J. Joshi, R. Forrest, R. Ruxer, H. Standiford, L. Leslie, J. Wade, and S. Schimpff. 1985. Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients. Antimicrob. Agents Chemother. 27:605-607.
8. Kemmerich, B., H. Warns, H. Lode, K. Borner, P. Koeppe, and H. Knothe. 1983. Multiple-dose pharmacokinelics of ceftazidime and its influence on fecal flora. Antimicrob. Agents Chemother. 24:333-338.
9. Kobasa, W. D., and D. Kake. 1983. Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits. Antimicrob. Agents Chemother. 24:321-324.
10. Lavoie, G. Y., and M. G. Bergeron. 1985. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots, and on in vivo efficacy against Haemophilus influenzae. Antimicrob. Agents Chemother. 28:404-412.
11. McColm, A. A., and R. D. Michael. 1985. Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 27:925-927.
12. National Committee for Clinical Laboratory Standards. 1990. Quality assurance standards for commercially prepared microbiological culture media approved standard. Publication M22-A. National Committee for Clinical Laboratory Standards, Villanova, Pa.
13. Nye, K., Y. G. Shi, J. M. Andrews, J. P. Ashby, and R. Wise. 1989. The in vitro activity, pharmacokinetics and tissue penetration of temafloxacin. J. Antimicrob. Ther. 24:415-423.
14. Pefanis, A., H. Giamarellou, P. Karayiannakos, and I. Donta. 1993. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Antimicrob. Agents Chemother. 37:308-313.
15. Tjandramaga, T. B., A. Van Hecken, A. Mullie, R. Verbessert, P. J. De Schepper, and L. Verbist. 1982. Comparative pharmacokinetics of ceftazidime and moxalactam. Antimicrob. Agents Chemother. 22:237-241.
16. Turcotte, A., and M. G. Bergeron. 1992. Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots. Antimicrob. Agents Chemother. 36:2211-2215.
17. van Ogtrop, M. L., H. Mattie, H. F. L. Guiot, E. van Strijen, A.-M. Hazekamp-van Dokkum, and R. van Furth. 1990. Comparative study of the effect of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrob. Agents Chemother. 34:1932-1937.
18. Youngs, D., D. W. Burdon, and M. R. B. Keighley. 1989. The penetration of aztreonam, a monobactam antibiotic, into intra-ahdominal abscesses. J. Antimicrob. Chemother. 24:425-429.